Evidence map›Paper›PMID 26432902›Full record

ArticleJournal of the American Society of Nephrology : JASN2016

The Choice of Hemodialysis Membrane Affects Bisphenol A Levels in Blood.

Enrique Bosch-Panadero, Sebastian Mas, Didier Sanchez-Ospina, Vanesa Camarero, Maria V Pérez-Gómez, Isabel Saez-Calero, Pedro Abaigar, Alberto Ortiz, Jesus Egido, Emilio González-Parra

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Associations between pediatric intensive care procedures and urinary free-BPA levels.Environmental science and pollution research international · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Current approaches to middle molecule removal: room for innovation.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Enrique Bosch-PanaderoRenal, Vascular and Diabetes Laboratory, and.
Sebastian MasRenal, Vascular and Diabetes Laboratory, and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain; smas@fjd.es.
Didier Sanchez-OspinaDivision of Nephrology and Hypertension, IIS-Fundación Jimenez Diaz Universidad Autónoma de Madrid (UAM), Madrid, Spain;
Vanesa CamareroDivision of Nephrology, Hospital Universitario de Burgos, Burgos, Spain;
Maria V Pérez-GómezDivision of Nephrology and Hypertension, IIS-Fundación Jimenez Diaz Universidad Autónoma de Madrid (UAM), Madrid, Spain; Red Española de Investigación Renal, Madrid, Spain;
Isabel Saez-CaleroDivision of Nephrology, Hospital Universitario de Burgos, Burgos, Spain;
Pedro AbaigarDivision of Nephrology, Hospital Universitario de Burgos, Burgos, Spain;
Alberto OrtizRenal, Vascular and Diabetes Laboratory, and Division of Nephrology and Hypertension, IIS-Fundación Jimenez Diaz Universidad Autónoma de Madrid (UAM), Madrid, Spain; Red Española de Investigación Renal, Madrid, Spain; Department of Medicine, UAM Medical School, Madrid, Spain; and Fundación Renal Íñigo Álvarez de Toledo/Instituto Reina Sofía de Investigación en Nefrología, Madrid, Spain.
Jesus EgidoRenal, Vascular and Diabetes Laboratory, and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain; Division of Nephrology and Hypertension, IIS-Fundación Jimenez Diaz Universidad Autónoma de Madrid (UAM), Madrid, Spain; Department of Medicine, UAM Medical School, Madrid, Spain; and Fundación Renal Íñigo Álvarez de Toledo/Instituto Reina Sofía de Investigación en Nefrología, Madrid, Spain.
Emilio González-ParraSpanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain; Division of Nephrology and Hypertension, IIS-Fundación Jimenez Diaz Universidad Autónoma de Madrid (UAM), Madrid, Spain; Red Española de Investigación Renal, Madrid, Spain; Department of Medicine, UAM Medical School, Madrid, Spain; and Fundación Renal Íñigo Álvarez de Toledo/Instituto Reina Sofía de Investigación en Nefrología, Madrid, Spain.
Hospital Universitario de Burgos · ESFundación Renal · ESSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ESHospital Universitario Fundación Jiménez Díaz · ESUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bisphenol A (BPA), a component of some dialysis membranes, accumulates in CKD. Observational studies have linked BPA exposure to kidney and cardiovascular injury in humans, and animal studies have described a causative link. Normal kidneys rapidly excrete BPA, but insufficient excretion may sensitize patients with CKD to adverse the effects of BPA. Using a crossover design, we studied the effect of dialysis with BPA-containing polysulfone or BPA-free polynephron dialyzers on BPA levels in 69 prevalent patients on hemodialysis: 28 patients started on polysulfone dialyzers and were switched to polynephron dialyzers; 41 patients started on polynephron dialyzers and were switched to polysulfone dialyzers. Results were grouped for analysis. Mean BPA levels increased after one hemodialysis session with polysulfone dialyzers but not with polynephron dialyzers. Chronic (3-month) use of polysulfone dialyzers did not significantly increase predialysis serum BPA levels, although a trend toward increase was detected (from 48.8±6.8 to 69.1±10.1 ng/ml). Chronic use of polynephron dialyzers reduced predialysis serum BPA (from 70.6±8.4 to 47.1±7.5 ng/ml, P<0.05). Intracellular BPA in PBMCs increased after chronic hemodialysis with polysulfone dialyzers (from 0.039±0.002 to 0.043±0.001 ng/10(6) cells, P<0.01), but decreased with polynephron dialyzers (from 0.045±0.001 to 0.036±0.001 ng/10(6) cells, P<0.01). Furthermore, chronic hemodialysis with polysulfone dialyzers increased oxidative stress in PBMCs and inflammatory marker concentrations in circulation. In vitro, polysulfone membranes released significantly more BPA into the culture medium and induced more cytokine production in cultured PBMCs than did polynephron membranes. In conclusion, dialyzer BPA content may contribute to BPA burden in patients on hemodialysis.

Indexed as

Membranes, ArtificialRenal DialysisAgedBenzhydryl CompoundsBiocompatible MaterialsBisphenol A CompoundsCross-Over StudiesHumansKidney Failure, ChronicPhenolsPolymersProspective StudiesSulfonesBenzhydryl CompoundsBiocompatible Materialsbisphenol ABisphenol A CompoundsMembranes, ArtificialPhenolsPolymerspolysulfone P 1700SulfonesESRDhemodialysisoxidative stress

Identifiers

PMID26432902
PMCPMC4849825
OpenAlexW2187780352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.